School of Medicine
Showing 1,321-1,340 of 2,414 Results
-
Gabriel Mannis
Associate Professor of Medicine (Hematology)
Current Research and Scholarly InterestsMy research focuses on the development of more effective, less toxic therapies for patients with AML and other high-risk hematologic malignancies. We study biologic correlates that predict response to therapy as well as factors/interventions that improve quality-of-life for patients struggling with blood-borne cancers.
-
Neha Maheshwari Mantri
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Neha Mantri serves as the Director of the Structural Imaging Program and Director of the Women’s Cardiology Clinic at Palo Alto VA Health Care System (PAVA HCS). Given her expertise in advanced imaging, she serves as a reader in the Echocardiography Lab at Stanford Hospital. She also leads several echocardiography quality improvement projects, weekly multi-modality imaging educational seminars, and fellow workshops across the PAVA HCS and Stanford echo labs.
-
Arek Melkon Manugian, MD
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Manugian is a board-certified internal medicine doctor at Stanford Primary Care in Portola Valley. He is also a clinical assistant professor in the Division of Primary Care and Population Health in the Department of Medicine at Stanford University School of Medicine.
He has experience diagnosing, managing, and treating a wide range of conditions. These include gastrointestinal disorders, hypertension (high blood pressure), and obesity. Dr. Manugian develops an individualized care plan for each one of his patients.
Dr. Manugian’s research interests include blood pressure medication, gastric bypass surgery, and restless legs syndrome. He received a student research grant to study how the body processes glucagon (a hormone that regulates blood sugar) following gastric bypass surgery. Dr. Manugian has also studied muscle inflammation as a rare side effect of statins (drugs that lower cholesterol). He monitored a clinical trial evaluating the prescribing of drugs to lower high blood pressure. As a clinical research associate at the Stanford University Center for Sleep Sciences and Medicine, Dr. Manugian studied medications to treat restless legs syndrome.
Dr. Manugian presented research to his peers during his residency at the University of Cincinnati Medical Center. He has taught medical students, residents, and physicians about a variety of topics, including alcohol abuse, tick-born illnesses, and managing indigestion.
Dr. Manugian is a member of the American College of Physicians. -
Jill Marcus
Senior Manager, CEC & Clinical Research, Med/Stanford Center for Clinical Research
Current Role at StanfordSenior Manager, CEC and Clinical Research
-
Robert Marcus
Professor (Clinical) of Medicine (Endocrinology, Gerontology and Metabolism), Emeritus
Current Research and Scholarly InterestsI have been retired since 2008 and no longer conduct research
-
Jessie Markovits, MD
Clinical Associate Professor, Medicine
Clinical Associate Professor (By courtesy), Psychiatry and Behavioral SciencesCurrent Research and Scholarly InterestsHypnosis for perioperative symptom management in elective orthopedic surgery.
-
Meghan Marmor
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioDr. Marmor is board certified in pulmonary and critical care medicine. She specializes in the treatment of individuals with chronic airway diseases, bronchiectasis, and chronic lung infections.
-
David J. Maron
C. F. Rehnborg Professor and Professor of Medicine (Stanford Prevention Research Center)
Current Research and Scholarly InterestsDr. Maron is the Co-Chair and Principal Investigator of the ISCHEMIA trial, and Co-Chair of the ISCHEMIA-CKD trial. These large, international, NIH-funded studies will determine whether an initial invasive strategy of cardiac catheterization and revascularization plus optimal medical therapy will reduce cardiovascular events in patients with and without chronic kidney disease and at least moderate ischemia compared to an initial conservative strategy of optimal medical therapy alone.
-
Ashley Martinez, MD, MAS
Clinical Assistant Professor, Medicine - Nephrology
BioDr. Ashley Martinez is a board-certified, fellowship-trained nephrologist with the Kidney and Pancreas Transplant Program at Stanford Health Care. She is also a clinical assistant professor in the Department of Medicine, Division of Nephrology at Stanford University School of Medicine.
Dr. Martinez specializes in caring for kidney transplant recipients. She has expertise in pre-transplant evaluation and readiness, immunosuppression, kidney allograft survival, and the prevention and treatment of post-transplant complications. She prioritizes clear, personalized communication at every point to improve care.
Dr. Martinez earned her medical degree from Harvard Medical School and completed her residency in internal medicine at Massachusetts General Hospital. She completed clinical and research fellowships in nephrology at the University of California, San Francisco (UCSF), where she also earned a master’s degree in clinical research. She completed her transplant nephrology fellowship at Stanford University School of Medicine.
Dr. Martinez’s research interests focus on addressing the needs of patients impacted by language barriers. Her work has emphasized the need to improve provider-patient communication, patient education, and evaluation tools for patients with limited English proficiency. She aims to increase awareness of communication gaps and increase patient-centered communication throughout the course of kidney care.
Dr. Martinez has published her findings in peer-reviewed journals including JAMA Network Open and Kidney360. She has also presented at the National Kidney Foundation Spring Clinical Meetings.
Dr. Martinez is a member of the American Society of Nephrology, the American Society of Transplantation, and the National Kidney Foundation.
